MDDiabeticPro
Discover, Control & Prevent diabetic risk.
How does MDDiabeticPro differ from other diabetes tests?
PMLS offers a variety of biomarkers on our diabetes test panel. Besides running a normal A1C test, PMLS goes further and tests a patient’s Fasting Glucose, GlycoMark, Adiponectin, Leptin, HOMA-IR, Insulin, and C-peptide, but we don’t stop there. To give patient’s a look at the bigger picture, we also run a Comorbidity Assessment of Cardiovascular and Renal biomarkers, as well as a Genetic Predisposition test called DIABETESpredict™. With DIABETESpredict™, doctors can help their patients know their risk for type 2 diabetes earlier.
MdDiabeticPro is also specifically designed to help Type 1 diabetes patients with the management of the disease. This test can be used for monitoring individuals who are pre-disposed to insulin resistance. The results of the test equip physicians with the information needed to fine tune nutrition and exercise plans, helping a T1D patient to make the use of insulin most effective.
Know your risk with DIABETESPredict™
DIABETESpredict™ is a genotyping tool for type 2 diabetes risk assessment. It analyzes the main genetic variants associated with T2D, taking into account multi-ethnic associations. DIABETESpredict™ identifies high risk individuals and gives them additional information to implement lifestyle changes. Early identification of type 2 diabetes enables prevention and with DIABETESpredict™ doctors are empowered to help their patients further.
500 Million worldwide suffer
type-2 diabetes.
34.2 Million Americans, or 10.5% of the population, had diabetes.
Let’s Talk
We want to hear from you! Tell us more about your interest in MDChemistryPro today.
Read Our Blog
How UDC Testing (Urine Drug Confirmation) Enhances Patient Care
Today, there are a good number of people living with chronic pain worldwide. They seek help from their doctors, and they’re often referred to a Pain Management Clinic. One of the most significant tools in a pain management clinic is Urine Drug Confirmation Testing, or...
Naysaying the Naysayers on the ICD-10 Rollout
“The transition from ICD9s to ICD10s is going to be disastrous for healthcare!” This was the statement heard so often for so long, that everyone in the industry was terrified about the transition from ICD-9 codes to ICD-10 codes and overjoyed every time a...
Three Pieces of Physician Office Lab Equipment to Know About
Medical Supplies & Equipment Medical supplies are vital instruments that help you administer the tests account for all of the findings. The next section shows some widely used equipment for POL (Physician Office Lab) testing. BC-3200 Auto Hematology Analyzer is...
10 Ridiculous ICD-10 Codes
ICD-10 went into effect in the United States on October 1, 2015. The primary difference from ICD-9 is the amount of specificity and granularity of conditions or situations which were given a code. In total, there are some 70,000 codes, which is up 500% from ICD-9...
Understanding CLIA and Waived Testing
Proper (CLIA) Waived Lab Testing & Protocols CLIA- Clinical Laboratory Improvement Amendments is to ensure timeliness, accurate, and reliability in patient testing. This act falls under strict, high quality standards, wherever the tests were performed. This...
How Pharmacogenomics Improves Patient Care
Since 2007, when the FDA acknowledged that a blood-thinning drug's effectiveness (or lack of) could be determined by how a person's unique genetic structure responded to dosage, the medical field has been questioning its trial-by-error methodology. Emerging from...